| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
21,989 | 24,536 | 20,961 | 17,343 | 0 | 0 | 0 |
General and administrative | ||||||
21,898 | 20,869 | 18,051 | 14,204 | 0 | 0 | 0 |
Total operating expenses | ||||||
43,887 | 45,405 | 39,012 | 31,547 | 0 | 0 | 0 |
Loss from operations | ||||||
-43,887 | -45,405 | -39,012 | -31,547 | 0 | 0 | 0 |
Other income (expense): | ||||||
Interest income | ||||||
3,799 | 2,517 | 0 | 0 | 0 | - | - |
Interest income, net (Note 4) | ||||||
- | 11 | 203 | -104 | 0 | 0 | 0 |
Accretion of debt discount (Note 4) | ||||||
- | 945 | 2,269 | 2,354 | 0 | 0 | 0 |
Change in fair value of derivative (Note 4) | ||||||
- | -135 | -2,768 | -484 | 0 | 0 | 0 |
Total other income (expense), net | ||||||
3,277 | 1,448 | -3,409 | -2,375 | 0 | 0 | 0 |
Net loss before income taxes | ||||||
-40,610 | -43,957 | -42,421 | -33,922 | 0 | 0 | 0 |
Net loss attributable to common stockholders | ||||||
-40,610 | -43,957 | -42,421 | -33,922 | 0 | 0 | 0 |
Net loss per share, basic and diluted (Note 7) | ||||||
-0.33 | 4,626.73 | -0.39 | -146.02 | -4,484.00 | -1,247,600.00 | - |
Weighted average common shares outstanding used in computing net loss per share, basic and diluted | ||||||
26,042 | 24,818 | 22,907 | 103 | 2 | 0 | - |